Tiziana Life Sciences (TILS)- Issue of Equity August 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 3rd August, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million New York and London, August 3, 2020 – Tiziana Life Sciences plc (NASDAQ: TLSA; AIM: TILS) (the “Company” or “Tiziana”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announced it has entered into definitive agreements with investors for the purchase and sale of 11,009,615 of the Company’s American Depositary Shares…

Tiziana Life Sciences #TILS – Announces Closing of Offering and Resulting Total Voting Rights March 16, 2020 – Posted in: Tiziana Life Sciences (TILS)

London, New York 16 March 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces the closing of its underwritten follow-on public offering (the “Offering”) of American Depositary Shares (“ADSs”) on the NASDAQ Global Market. Tiziana issued 3,333,333 ADSs (representing 16,666,665 new ordinary shares…

Tiziana Life Sciences (TILS)- Issue of Equity August 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences #TILS – Announces Closing of Offering and Resulting Total Voting Rights March 16, 2020 – Posted in: Tiziana Life Sciences (TILS)

Address

Contact

Social

LEGAL